3192 results for «600»
3192 results
PCI for complex coronary lesions
18 May 2023 – From EuroPCR 2023
Gain valuable insights into the management of challenging coronary lesions during PCI in this session: witness the effective treatment of in-stent restenosis through the innovative use of intravascular lithotripsy, explore the techniques employed to address non-expandable stents, discover the utility of the Guide Extension catheter system...
Bailouts for PCI complications
18 May 2023 – From EuroPCR 2023
Experience the high-stakes world of bailouts for PCI complications in this session: witness the intricate management of a catastrophic RCA dissection (Type F), delve into the challenges posed by a catastrophic left internal mammary artery graft spasm, uncover the complexities of managing no reflow with cardiogenic...
How to treat coronary aneurysm
18 May 2023 – From EuroPCR 2023
Treating coronary aneurysms requires careful consideration and depends on several facors such as specifics characteristics of the aneurysms and patient’s conditions. Learn more the way to treat them throught this series of cases: massive thrombosis of an RCA aneurysm ; new insight toward understanding WOVEN like...
Intracoronary imaging in left main - Part 1
18 May 2023 – From EuroPCR 2023
Explore the world of intracoronary imaging in left main interventions in this session: discover a fascinating case report on overcoming left main stent pop-up, delve into the application of OCT-guided nano crush technique for left main bifurcation lesions, uncover the management of stent failure involving the...
Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)
18 May 2023 – From EuroPCR 2023
Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.
Management of PCI complications
16 May 2023 – From EuroPCR 2023
Listen to speakers explore the landscape of PCI complications, dissecting their impact, strategies for skillful management and ways to optimize patient outcomes. Advance your own understanding of this important problem and discover a range of approaches to mitigating it.
Shock with valve disease - Part 1
17 May 2023 – From EuroPCR 2023
Discover here some compelling clinical cases on shock and valve disease. Experience real-life scenarios that will help you gain valuable knowledge and improve your clinical decision-making skills.
Aortic complications
17 May 2023 – From EuroPCR 2023
Enhance your understanding of managing aortic complications effectively by exploring a comprehensive series of clinical cases presented at EuroPCR. Cases studied include in particular – How to manage iatrogenic aortic dissection during TAVI- Pseudoaneurysm after TAVI, how to close the hole- Aortic dissection following TAVI and...
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)